as well as L. Luznik and E.H. Warren, contributed equally to this work. Conflict of interest: H.S. Robins has consultancy, equity ownership, patents, and royalties with Adaptive Biotechnologies Inc., which performed much of the antigen receptor sequencing described in this work.